---
figid: PMC4646237__zbc0471529000009
figtitle: Kinome Screen Identifies PFKFB3 and Glucose Metabolism as Important Regulators
  of the Insulin/Insulin-like Growth Factor (IGF)-1 Signaling Pathway
organisms:
- Mus musculus
- Homo sapiens
pmcid: PMC4646237
filename: zbc0471529000009.jpg
figlink: /pmc/articles/PMC4646237/figure/F9/
number: F9
caption: Model. The insulin/IGF-1 signaling pathway (purple) results in translocation
  of GLUT4 vesicles to the PM, facilitating increased glucose uptake. Glucose can
  either be converted to lactate (aerobic glycolysis, green) or undergo oxidative
  phosphorylation in the mitochondria (red). PFKFB3 generates Fru-2,6-BP (F2,6BP),
  a potent activator of PFK-1 and thus glycolysis. The insulin/IGF-1 signaling pathway
  positively regulates glucose uptake and glucose metabolism (purple arrow) and our
  data show that partitioning of glucose toward aerobic glycolysis potentiates insulin
  signaling (green arrow), whereas we predict that this effect will either not be
  seen or even inhibited when glucose undergoes mitochondrial oxidative phosphorylation.
  Drugs/inhibitors used in the study and their targets are indicated. G6P, glucose
  6-phosphate; F6P, fructose 6-phosphate; F1,6BP, fructose 1,6-bisphosphate.
papertitle: Kinome Screen Identifies PFKFB3 and Glucose Metabolism as Important Regulators
  of the Insulin/Insulin-like Growth Factor (IGF)-1 Signaling Pathway.
reftext: Sophie Trefely, et al. J Biol Chem. 2015 Oct 23;290(43):25834-25846.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.956344
figid_alias: PMC4646237__F9
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC4646237__F9
ndex: 9a5ee335-dee8-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4646237__zbc0471529000009.html
  '@type': Dataset
  description: Model. The insulin/IGF-1 signaling pathway (purple) results in translocation
    of GLUT4 vesicles to the PM, facilitating increased glucose uptake. Glucose can
    either be converted to lactate (aerobic glycolysis, green) or undergo oxidative
    phosphorylation in the mitochondria (red). PFKFB3 generates Fru-2,6-BP (F2,6BP),
    a potent activator of PFK-1 and thus glycolysis. The insulin/IGF-1 signaling pathway
    positively regulates glucose uptake and glucose metabolism (purple arrow) and
    our data show that partitioning of glucose toward aerobic glycolysis potentiates
    insulin signaling (green arrow), whereas we predict that this effect will either
    not be seen or even inhibited when glucose undergoes mitochondrial oxidative phosphorylation.
    Drugs/inhibitors used in the study and their targets are indicated. G6P, glucose
    6-phosphate; F6P, fructose 6-phosphate; F1,6BP, fructose 1,6-bisphosphate.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1
  - CLTC
  - SLC4A1
  - IGF1R
  - SLC2A4
  - CMA1
  - SLC16A1
  - MCAT
  - MCTS1
  - IRS1
  - PFKFB3
  - F2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PFKM
  - AKT1
  - AKT2
  - AKT3
  - GSK3A
  - GSK3B
  - TBC1D4
  - AKT1S1
  - Igf1
  - Cltc
  - Slc2a4
  - mct1
  - Slc16a1
  - Mcts1
  - Irs1
  - Pfkfb3
  - Pik3r1
  - Akt1
  - Gsk3b
  - Tbc1d4
  - Akt1s1
  - Glucose
  - Pyruvate
  - Glucose Lactate
  - Lactate
  - Diabetes mellitus
---
